Skip to main
BIIB
BIIB logo

Biogen (BIIB)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Biogen (BIIB) Stock

About Biogen (BIIB)

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque p...read more
Market cap$18.4B
Yesterday's volume1.28M
Revenue (TTM)$9.4B
Avg. daily volume1.64M
EBITDA (TTM)$2.88B
Open$126.30
Price / earnings ratio12.40x
Yesterday's range$123.9 - $126.53
Debt / equity39x
52 week range$110.04 - $238
5 year debt / equity52.18x
Beta (LTM)0.6x
Interest coverage8.38x
Dividend & yield$0.00 (0.00%)
Current ratio1.44x
Ex-dividend date
Next earningsJul 31, 2025
Dividend payable date

Biogen Stock Rating

What analysts recommend for BIIB stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 36%
Buy 33%
Hold 31%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for Biogen stock is $18.41B

The current P/E ratio for Biogen stock is 12.4

The 52-week high for Biogen stock is $238. The current Biogen stock price $undefined is 100.00% below its 52-week high

The 52-week low for Biogen stock is $110.04. The current Biogen stock price $undefined has increased 100.00% from its 52-week low

No, the Biogen stock does not pay dividends to its shareholders

The target price for Biogen stock is $252.36 based on the average of what a group of analyst think Biogen stock could be worth at a future date. This is not a prediction by Public.com

How to buy Biogen stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Biogen stock

    Navigate to the Explore page. Then, type Biogen into the search bar. When you see Biogen stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Biogen stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Biogen Stock Earnings

The value each BIIB share was expected to gain vs. the value that each BIIB share actually gained.

Biogen (BIIB) reported Q1 2025 earnings per share (EPS) of $3.02, beating estimates of $2.52 by 19.84%. In the same quarter last year, Biogen's earnings per share (EPS) was $3.67. Biogen is expected to release next earnings on 07/31/2025, with an earnings per share (EPS) estimate of $4.06.

Buy Biogen (BIIB) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.